Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...
the ‘wonder’ cream is also the first of its kind to have been classified as a Class 1 Medical Device to treat the symptoms of ...